Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,775 INR | +4.93% | +6.02% | +7.64% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.64% | 2.63B | |
-24.06% | 7.68B | |
+75.42% | 4.31B | |
-2.10% | 2.66B | |
-47.96% | 2.11B | |
-16.63% | 1.7B | |
-19.51% | 1.5B | |
+18.29% | 1.16B | |
-44.77% | 1.11B | |
-7.28% | 976M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024